Want to see KR:011000 full AI Analyst Report?
GeneOne Life Science, Inc. (011000) Income Statement
GeneOne Life Science, Inc. Income Statement
Last quarter (Q1 2026), GeneOne Life Science, Inc.'s total revenue was $2.58B, a decrease of 69.65% from the same quarter last year. In Q1, GeneOne Life Science, Inc.'s net income was $-2.38B. See GeneOne Life Science, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 23.93B | $ 35.72B | $ 40.20B | $ 48.72B | $ 38.70B | |
| $ -21.43B | $ -10.87B | $ -7.76B | $ 9.34B | $ 8.76B | |
| $ 21.00B | $ 32.17B | $ 40.61B | $ 49.42B | $ 36.26B | |
| Depreciation and Amortization | $ 18.20B | $ 17.96B | $ 12.78B | $ 5.42B | $ 4.65B |
| $ -28.60B | $ -28.64B | $ -63.70B | $ -25.32B | $ -6.51B | |
| $ -42.42B | $ -43.04B | $ -48.37B | $ -40.08B | $ -27.51B | |
| $ -5.15B | $ -5.71B | $ -29.29B | $ 2.03B | $ 11.90B | |
| $ -47.57B | $ -48.75B | $ -77.65B | $ -38.05B | $ -15.62B | |
| $ -47.66B | $ -48.54B | $ -77.77B | $ -38.15B | $ -15.95B | |
| Per Share Metrics | |||||
| Basic EPS | $ -13951.00 | $ -15220.25 | $ -25005.75 | $ -12308.75 | $ -5371.50 |
| Diluted EPS | $ -13951.00 | $ -15220.25 | $ -25005.75 | $ -12308.75 | $ -5371.50 |
| Weighted Average Shares Outstanding | 3.42M | 3.18M | 3.11M | 3.10M | 2.97M |
| Weighted Average Shares Outstanding (Diluted) | 3.42M | 3.18M | 3.11M | 3.10M | 2.97M |
Currency in KRW
